Ondansetron
Product Images NDC 67877-169

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67877-169). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondan Structure)

Chemical structure of ondansetron hydrochloride dihydrate, showing its molecular arrangement including an indole ring, a ketone group, and a methyl-substituted imidazole ring.*

FDA Label Image

4 mg Container Label (Ondan4mglabel)

Ondansetron Tablets USP 4 mg label from Ascend Laboratories, LLC. The label specifies 30 tablets per container with prescription use only. It includes storage instructions (20°-25°C), dosage reference, and manufacturing details from Natco Pharma Limited, India. The label also features the NDC code 67877-169-30 and barcode.*

FDA Label Image

8 mg Container Label (Ondan8mglabel)

Ondansetron Tablets USP 8 mg label from Ascend Laboratories, LLC. The label indicates each tablet contains 10 mg ondansetron hydrochloride dihydrate equivalent to 8 mg ondansetron. The package contains 30 tablets and is labeled for prescription use only. Storage instructions and manufacturing information, including Natco Pharma Limited India as manufacturer, are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.